Symptomatic therapy and neurorehabilitation in multiple sclerosis

Area of Science:

• Neurology
• Rehabilitation Medicine
• Quality of Life Studies

Background:

• Multiple sclerosis (MS) causes progressive functional deficits, impacting independence and quality of life.
• Key MS symptoms include fatigue, bladder/bowel issues, sexual dysfunction, cognitive/affective disorders, and spasticity.
• Current symptomatic therapies have limitations and potential side effects; some symptoms like weakness are not drug-amenable.

Purpose of the Study:

• To provide an updated overview of symptom management and rehabilitation strategies for MS.
• To highlight how appropriate treatments can mitigate long-term MS consequences.
• To emphasize the role of neurorehabilitation in improving patient function and independence.

Main Methods:

• Review of pharmacological treatments for primary MS symptoms.
• Discussion of comprehensive, multidisciplinary neurorehabilitation approaches.
• Analysis of factors influencing treatment adaptation and long-term outcomes.

Main Results:

• Symptomatic therapies offer benefits but are limited by side effects.
• Neurorehabilitation improves self-performance, independence, and participation in social activities.
• Quality of life in MS is more influenced by disability and handicap than disease progression.

Conclusions:

• Personalized rehabilitation and symptom management are crucial for improving quality of life in MS patients.
• Interventions should be tailored to individual needs, environmental demands, and disability levels.
• Improvements from rehabilitation can be sustained through home-based support and adaptation.